New ultrasound test could spot dangerous heart blockages faster
NCT ID NCT05694065
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new way to diagnose blocked heart arteries using an ultrasound-based method called Ultrasonic Flow Ratio (UFR). It involves 112 people with suspected heart disease. The goal is to see if UFR can accurately identify significant blockages compared to the current standard test (FFR). If it works, this could make diagnosis quicker and less invasive.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ultrasonic Flow Ratio (UFR) assessment
What this could lead to
If successful, UFR could provide a faster, less invasive way to diagnose significant coronary blockages during standard angiography.
What could go wrong
This is a small, early-stage diagnostic study (112 participants) comparing UFR to an existing reference standard (FFR). It does not test treatment outcomes, so even if accurate, it may not improve patient health directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC HEART DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200025, China